European Journal of Vascular & Endovascular Surgery
Volume 33, Issue 2 , Pages 192-201 , February 2007

The Rationale for Using HMG-CoA Reductase Inhibitors (‘Statins’) in Peripheral Arterial Disease

  • G. Erez
    • ,
  • E. Leitersdorf

      Affiliations

    • Corresponding Author InformationCorresponding author. E. Leitersdorf, MD, Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah Hebrew University Medical Center, Kyriat Hadassah, Ein Kerem, P.O. Box 12221, 91120 Jerusalem, Israel.

,Accepted 24 November 2006.

 One of a series of educational articles edited by Janet Powell, UK.

PII: S1078-5884(06)00678-2

doi: 10.1016/j.ejvs.2006.11.020

European Journal of Vascular & Endovascular Surgery
Volume 33, Issue 2 , Pages 192-201 , February 2007

Article Tools

* Image Usage & Resolution